Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com recommends buying Bharti Airtel, HDIL and Ajanta Pharma.
Ashwani Gujral of ashwanigujral.com recommends selling Bank of Baroda and advises buying Dish TV and Ajanta Pharma.
Ashwani Gujral of ashwanigujral.com recommends selling Bank of Baroda and advises buying Ajanta Pharma and Motherson Sumi Systems.
Sudarshan Sukhani of s2analytics.com is of the view that one may short Just Dial and BEML.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Union Bank, Karnataka Bank and Havells India.
Manish Sharma of derivativetradingresearch is of the view that one may buy Ajanta Pharma with a target of Rs 1570.
Chandan Taparia, Derivative & Technical Analyst at Anand Rathi Securities is of the view that one can buy Havells India, TVS Motor and Ajanta Pharma and advises selling Union Bank.
Sudarshan Sukhani of s2analytics.com recommends buying Bajaj Finance, Maruti Suzuki and Ajanta Pharma.
According to Ashwani Gujral of ashwanigujral.com, one can buy Sobha, SRF, Ajanta Pharma and HDFC.
Vishal Malkan of malkansview.com advises buying Bata India with a target of Rs 590.
Manish Sharma of derivativetradingresearch is of the view that one may buy L&T Finance with a target of Rs 78.
Sandeep Wagle of powermywealth.com recommends buying Zee Entertainment, Kotak Mahindra Bank and Ajanta Pharma and advises selling UPL.
Ashwani Gujral of ashwanigujral.com recommends buying Ajanta Pharma, DLF and Canara Bank.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Divis Lab and PVR.
Ashwani Gujral of ashwanigujral.com is of the view that one can sell Havells India while one can buy Bank of Baroda and TVS Motor Company.
Shahina Mukadam, Independent Market Expert suggests buying JK Tyres with a target of Rs 86.
Ashwani Gujral of ashwanigujral.com recommends buying Jain Irrigation Systems, midcap pharma, Reliance Capital and Reliance Infrastructure.
Shahina Mukadam, Independent Market Expert is of the view that one may buy Tata Power with a target of Rs 69.5.
Rakesh Bansal of RK Global recommends buying Ajanta Pharma, BPCL, Granules India and Power Grid.
Manas Jaiswal of manasjaiswal.com suggests buying L&T Finance Holdings with a target of Rs 77.
Sandeep Wagle of powermywealth.com recommends buying Just Dial and Ajanta Pharma and advises selling BEML.
Ashwani Gujral of ashwanigujral.com recommends buying Torrent Pharma and Ajanta Pharma and advises selling Mindtree.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy India Cements and Havells India.
Ruchit Jain of Angel Broking recommends selling Bharat Heavy Electricals with a target of Rs 104 and advises buying Ajanta Pharma with a target of Rs 1495.
According to Sudarshan Sukhani of s2analytics.com, Ajanta Pharma, Container Corporation of India and Havells India are investment buying opportunities.